Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate vs Placebo in Inoperable Hepatocellular Carcinoma
NCT00041275Phase 3Completed
- Sponsor
- National Medical Research Council
- Start
- May 2002
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 3, randomised, double-blind trial in hepatocellular carcinoma (HCC) comparing Megestrol Acetate with Placebo (2 arms). Primary endpoint: Overall Survival. Started May 2002; status: completed.
02
Drugs
megestrol
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00041275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041275.